PT3283171T - Derivados de anfotericina b - Google Patents

Derivados de anfotericina b

Info

Publication number
PT3283171T
PT3283171T PT167808138T PT16780813T PT3283171T PT 3283171 T PT3283171 T PT 3283171T PT 167808138 T PT167808138 T PT 167808138T PT 16780813 T PT16780813 T PT 16780813T PT 3283171 T PT3283171 T PT 3283171T
Authority
PT
Portugal
Prior art keywords
amphotericin
derivatives
Prior art date
Application number
PT167808138T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Sfunga Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sfunga Therapeutics Inc filed Critical Sfunga Therapeutics Inc
Publication of PT3283171T publication Critical patent/PT3283171T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PT167808138T 2015-04-15 2016-04-15 Derivados de anfotericina b PT3283171T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562147949P 2015-04-15 2015-04-15

Publications (1)

Publication Number Publication Date
PT3283171T true PT3283171T (pt) 2021-07-14

Family

ID=57126898

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167808138T PT3283171T (pt) 2015-04-15 2016-04-15 Derivados de anfotericina b

Country Status (7)

Country Link
US (3) US9957290B2 (OSRAM)
EP (2) EP3929203A1 (OSRAM)
JP (3) JP7240811B2 (OSRAM)
CA (2) CA3213127A1 (OSRAM)
ES (1) ES2880029T3 (OSRAM)
PT (1) PT3283171T (OSRAM)
WO (1) WO2016168568A1 (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105848721B (zh) 2013-10-07 2019-08-23 伊利诺伊大学评议会 具有提高的治疗指数的两性霉素b衍生物
MA39568A1 (fr) * 2014-06-12 2017-09-29 Shionogi & Co Dérivé de macrolide de polyène
WO2016168568A1 (en) * 2015-04-15 2016-10-20 Revolution Medicines, Inc. Derivatives of amphotericin b
WO2017100171A1 (en) * 2015-12-08 2017-06-15 Kalyra Pharmaceuticals, Inc. Antifungal compounds and methods
WO2018106571A1 (en) * 2016-12-06 2018-06-14 Kalyra Pharmaceuticals, Inc. Antifungal compounds and methods
JP7477177B2 (ja) * 2018-09-07 2024-05-01 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ 毒性が低減されたハイブリッドアムホテリシンb誘導体
EP4009984A4 (en) * 2019-08-08 2023-09-06 The Board Of Trustees Of The University Of Illinois HYBRID AMPHOTERICIN B DERIVATIVES WITH REDUCED TOXICITY
AU2020325163A1 (en) * 2019-08-08 2022-03-03 The Board Of Trustees Of The University Of Illinois Hybrid amide derivatives of amphotericin B
FR3112145A1 (fr) * 2020-07-03 2022-01-07 Nanotracks Diagnostics Derives uree de macrolides polyeniques, composes chimiques particuliers susceptibles d’etre utilises pour obtenir ces derives uree, compositions les contenant et utilisations
WO2022003181A1 (fr) * 2020-07-03 2022-01-06 Nanotracks Diagnostics Derivés urée de l'amphotéricine amb, compositions les contenant et leurs utilisations, dérivés isocyanate d'alkyle omega-aminés et leur utilisation pour obtenir lesdits dérivés urée
EP4192248B1 (en) * 2020-08-10 2025-12-03 The Board Of Trustees Of The University Of Illinois Hybrid amide derivatives of amphotericin b

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8829592D0 (en) 1988-12-19 1989-02-08 Beecham Group Plc Novel compounds
EP0350164A3 (en) * 1988-06-13 1991-07-24 Beecham Group Plc Amphotericin derivatives
EP0431870A1 (en) * 1989-12-08 1991-06-12 Beecham Group p.l.c. Amphotericin B derivatives
JP3507486B2 (ja) 1991-03-15 2004-03-15 アムジエン・インコーポレーテツド 顆粒球コロニー刺激因子の肺内投与
GB9203476D0 (en) 1992-02-19 1992-04-08 Smithkline Beecham Plc Novel compounds
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US5606038A (en) 1995-04-10 1997-02-25 Competitive Technologies, Inc. Amphiphilic polyene macrolide antibiotic compounds
PL180253B1 (pl) * 1995-05-13 2001-01-31 Politechnika Gdanska Pochodne N-metylo-N-glikozylowe estrów metylowych antybiotyków z grupy makrolidów polienowych i ich sole oraz sposób ich otrzymywania PL PL PL PL PL PL
US6664241B2 (en) 2000-05-31 2003-12-16 Micrologix Biotech Inc. Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof
EP1987049A1 (en) * 2006-02-23 2008-11-05 ETH Zürich Amphotericin derivatives
JP5240704B2 (ja) * 2007-10-05 2013-07-17 国立大学法人群馬大学 新規蛍光化合物およびそれを用いた細胞内コレステロールの検出方法
WO2013186384A1 (en) 2012-06-15 2013-12-19 Blirt S.A. N-substituted second generation derivatives of antifungal antibiotic amphotericin b and methods of their preparation and application
WO2014165676A1 (en) 2013-04-03 2014-10-09 The Board Of Trustees Of The University Of Illinois Amphotericin b derivative with reduced toxicity
CN105848721B (zh) * 2013-10-07 2019-08-23 伊利诺伊大学评议会 具有提高的治疗指数的两性霉素b衍生物
WO2015164289A1 (en) * 2014-04-21 2015-10-29 Cidara Therapeutics, Inc. Compositions and methods for the treatment of fungal infections
JP6543272B2 (ja) 2014-05-16 2019-07-10 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイThe Board Of Trustees Of The University Of Illinois 低減された毒性を有するアンホテリシンb誘導体
MA39568A1 (fr) 2014-06-12 2017-09-29 Shionogi & Co Dérivé de macrolide de polyène
WO2016014779A1 (en) 2014-07-23 2016-01-28 The Board Of Trustees Of The University Of Illinois Antifungal polyene macrolide derivatives with reduced mammalian toxicity
WO2016040779A1 (en) 2014-09-12 2016-03-17 The Board Of Trustees Of The University Of Illinois Urea derivatives of polyene macrolide antibiotics
US10087206B2 (en) 2014-10-17 2018-10-02 The Board Of Trustees Of The University Of Illinois Scalable synthesis of reduced toxicity derivative of amphotericin B
WO2016112243A1 (en) 2015-01-08 2016-07-14 The Board Of Trustees Of The University Of Illinois Urea derivatives of amphotericin b derived from secondary amines
US20180273571A1 (en) 2015-01-08 2018-09-27 The Board Of Trustees Of The University Of Illinois Concise synthesis of urea derivatives of amphotericin b
WO2016168568A1 (en) * 2015-04-15 2016-10-20 Revolution Medicines, Inc. Derivatives of amphotericin b

Also Published As

Publication number Publication date
JP2018514522A (ja) 2018-06-07
US10882883B2 (en) 2021-01-05
EP3283171B1 (en) 2021-05-26
WO2016168568A1 (en) 2016-10-20
US9957290B2 (en) 2018-05-01
CA3021061C (en) 2023-10-24
JP7240811B2 (ja) 2023-03-16
CA3213127A1 (en) 2016-10-20
US20160304548A1 (en) 2016-10-20
US20200262858A1 (en) 2020-08-20
JP2021075570A (ja) 2021-05-20
HK1244248A1 (zh) 2018-08-03
CA3021061A1 (en) 2016-10-20
ES2880029T3 (es) 2021-11-23
US10597420B2 (en) 2020-03-24
EP3283171A4 (en) 2019-03-13
JP2023030103A (ja) 2023-03-07
EP3929203A1 (en) 2021-12-29
US20180273572A1 (en) 2018-09-27
EP3283171A1 (en) 2018-02-21

Similar Documents

Publication Publication Date Title
ZA201800826B (en) Substituted oxopyridine derivatives
SG11201706729SA (en) Derivatives of sobetirome
IL257026A (en) Solid state forms of eluxadoline
IL253381A0 (en) History of h9-pyrrolo-dipyridine
PT3283171T (pt) Derivados de anfotericina b
SMT202100551T1 (it) Derivati di sobetirome
SI3845221T1 (sl) Trdne oblike sofosbuvirja
SI3380554T1 (sl) Kristalne oblike per-kloro-gama-ciklodekstrinov
PT3334734T (pt) Forma c de avibactam sódico
PL3164393T3 (pl) Pochodne flawaglin
HUE050450T2 (hu) Fluoralkil-fluorén-származékok
IL246979A0 (en) Crystalline forms of sofosbuvir
IL248773A0 (en) History of naphthyridinedione
SG10202101979TA (en) Crystalline forms of c21h22ci2n4o2
ZA201706282B (en) Solid forms of menaquinols
GB201604627D0 (en) Improved method of FT-IMS
IL251005B (en) Pyrido-oxazinone derivatives
IL248629A0 (en) Substances containing diheteroaryl conjugated to cycloalkyl and their uses
IL253479A0 (en) Crystalline forms of efinconazole
PL3119744T3 (pl) Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu
IL249130B (en) Preparation of piperidine-4-carbothioamide
IL249332A0 (en) Crystalline forms of sofosbuvir
PH32015000758S1 (en) Set of earbuds
GB201405156D0 (en) Theory of parliament
GB201501636D0 (en) Pair of planes